In vitro inhibition of fVIII by plasma from a patient with congenital hemophilia A and high-titer inhibitor. fVIII was reconstituted into hemophilia A plasma at the indicated concentrations, and the inhibition of fVIII by patient plasma was measured by a 1-stage coagulation assay. The curves represent 4-parameter logistic fits to the data.